Ori Biotech Expands Team to Advance IRO Commercialization and Industry Partnerships
January 09, 2025 08:30 ET
|
Oribiotech Ltd
Ori Biotech announces the appointment of two new members to its senior team and new members to its Strategic Advisory Board (SAB).
Ori Biotech Announces First Customer Deliveries of IRO to Leading CDMOs and Commercial CGT Manufacturers
January 07, 2025 08:30 ET
|
Ori Biotech Ltd
Ori Biotech announces the first customer deliveries of the IRO® platform, designed to help address the current challenges in CGT manufacturing.
Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies
December 10, 2024 08:31 ET
|
Ori Biotech Ltd
Ori Biotech and Fresenius Kabi partner to integrate Ori’s IRO® Platform with Cue® and Lovo® systems, advancing scalable cell and gene therapy manufacturing
Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing
September 18, 2024 08:30 ET
|
Ori Biotech Ltd
PHILADELPHIA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, and Charles River Laboratories (Charles River), a...
Ori Biotech and CTMC Present Scientific Data for New IRO® Platform at ISCT 2024
June 03, 2024 09:30 ET
|
Ori Biotech Ltd
Ori Biotech and CTMC announce promising results for IRO, Ori’s newly launched next-generation CGT manufacturing enabling platform.
Ori Biotech Unveils IRO Platform at Annual International Society for Cell & Gene Therapy Conference
May 29, 2024 15:30 ET
|
Ori Biotech Ltd
Ori Biotech announces the commercial launch of IRO, a next-generation platform built to overcome the challenges of cell therapy manufacturing, at ISCT 2024